Next Article in Journal
Gaps and Delays in Survivorship Care in the Return-to-Work Pathway for Survivors of Breast Cancer—A Qualitative Study
Previous Article in Journal
Position Statement on Defining and Standardizing an Oncoplastic Approach to Breast-Conserving Surgery in Canada
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Framing of the Opioid Problem in Cancer Pain Management in Canada

1
Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
2
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
3
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(3), 410-413; https://doi.org/10.3747/co.26.4517
Submission received: 6 March 2019 / Revised: 5 April 2019 / Accepted: 8 May 2019 / Published: 1 June 2019

Abstract

Two guidelines about opioid use in chronic pain management were published in 2017: the Canadian Guideline for Opioids for Chronic Non-Cancer Pain and the European Pain Federation position paper on appropriate opioid use in chronic pain management. Though the target populations for the guidelines are the same, their recommendations differ depending on their purpose. The intent of the Canadian guideline is to reduce the incidence of serious adverse effects. Its goal was therefore to set limits on the use of opioids. In contrast, the European Pain Federation position paper is meant to promote safe and appropriate opioid use for chronic pain. The content of the two guidelines could have unintentional consequences on other populations that receive opioid therapy for symptom management, such as patients with cancer. In this article, we present expert opinion about those chronic pain management guidelines and their impact on patients with cancer diagnoses, especially those with histories of substance use disorder and psychiatric conditions. Though some principles of chronic pain management can be extrapolated, we recommend that guidelines for cancer pain management should be developed using empirical data primarily from patients with cancer who are receiving opioid therapy.
Keywords: chronic pain; cancer pain; pain; opioids; Canadian pain guideline (2017); European pain guideline (2017); mental health; substance use disorders chronic pain; cancer pain; pain; opioids; Canadian pain guideline (2017); European pain guideline (2017); mental health; substance use disorders

Share and Cite

MDPI and ACS Style

Asthana, R.; Goodall, S.; Lau, J.; Zimmermann, C.; Diaz, P.L.; Wan, A.B.; Chow, E.; De Angelis, C. Framing of the Opioid Problem in Cancer Pain Management in Canada. Curr. Oncol. 2019, 26, 410-413. https://doi.org/10.3747/co.26.4517

AMA Style

Asthana R, Goodall S, Lau J, Zimmermann C, Diaz PL, Wan AB, Chow E, De Angelis C. Framing of the Opioid Problem in Cancer Pain Management in Canada. Current Oncology. 2019; 26(3):410-413. https://doi.org/10.3747/co.26.4517

Chicago/Turabian Style

Asthana, R., S. Goodall, J. Lau, C. Zimmermann, P. L. Diaz, A. B. Wan, E. Chow, and C. De Angelis. 2019. "Framing of the Opioid Problem in Cancer Pain Management in Canada" Current Oncology 26, no. 3: 410-413. https://doi.org/10.3747/co.26.4517

APA Style

Asthana, R., Goodall, S., Lau, J., Zimmermann, C., Diaz, P. L., Wan, A. B., Chow, E., & De Angelis, C. (2019). Framing of the Opioid Problem in Cancer Pain Management in Canada. Current Oncology, 26(3), 410-413. https://doi.org/10.3747/co.26.4517

Article Metrics

Back to TopTop